Proteins that terminally fail to acquire their native structure are detected and degraded by cellular quality control systems. Insights into cellular protein quality control are key to better understand how cells establish and maintain the integrity of their proteome and how failures in these processes cause human disease. Here, we use genetic code expansion and fast bioorthogonal reactions to monitor protein turnover in mammalian cells by a fluorescence-based assay. We use immune signaling molecules (interleukins) as model substrates and show that our approach preserves normal cellular quality control and assembly processes, protein functionality and works for different proteins and fluorophores. We further extend our approach to a pulse-chase type of assay which can provide kinetic insights into cellular protein behavior. Taken together, this study establishes a minimally-invasive method to investigate protein turnover in cells as a key determinant of cellular homeostasis.
Introduction
In order to become biologically active, most proteins have to adopt a defined three-dimensional structure, i.e. fold. Protein folding is among the most fundamental processes of self-organization in living systems and at the same time highly complex: In a correctly structured protein, thousands of atoms each adopt a well-defined position in space. 1 Accordingly, cells have developed a comprehensive machinery of protein folding helpers, molecular chaperones, to aid protein folding -but also to scrutinize its success and degrade proteins that do not achieve their native structure. 2 Failures in these processes give rise to protein misfolding disorders like Parkinson's or Alzheimer's disease. 3 Within a mammalian cell, the endoplasmic reticulum (ER) is specialized in the production and folding of membrane and secreted proteins. 4 These proteins mediate cellular communication, transport processes and coordinated development, and in total make up more than one third of a typical mammalian proteome. 5 As such, the ER can be considered a bona fide protein folding factory in the cell, which also sets the standards if a protein shall be transported to the cell surface or shall be degraded if it fails to fold. 6 This process is termed ER quality control (ERQC). Generally, proteins that fail to acquire their native structure in the ER are eliminated in a process called ER-associated degradation (ERAD). 7 ERAD includes recognition of misfolded proteins in the ER, their retrotranslocation back to the cytosol, ubiquitination and subsequent degradation by the major proteolytic machinery of the cell, the proteasome. 7, 8 Its fundamental role in cell biology as well as its immediate involvement in human disease have spurred a great interest in understanding the molecular basis of ERAD 9 as well as in developing techniques to monitor this process. [10] [11] [12] The site-specific incorporation of unnatural amino acids (UAAs) via genetic code expansion and their subsequent chemoselective labeling with fluorescent probes may present an ideal tool to monitor ERAD and protein turnover in general. 13 Recent years have seen tremendous progress in the development of rapid and selective bioorthogonal reactions such as the inverse electrondemand Diels-Alder cycloaddition (iEDDAC) between strained dienophiles and tetrazines. [14] [15] [16] [17] Unnatural amino acids bearing strained alkenes or alkynes such as bicyclo[6.1.0]nonyne (BCNK) 16, 18 and trans-cyclooctene (TCOK) 16, 17 have been incorporated site-specifically into proteins in E. coli and mammalian cells using specific and orthogonal Pyrrolysyl-tRNA synthetase (PylRS)/tRNACUA pairs. Rapid iEDDAC with tetrazine fluorophore conjugates allows the site-specific and selective labeling of proteins in living cells with a diverse range of fluorophores. 16, 17 and has been used for imaging of cell-surface and intracellular proteins [19] [20] [21] [22] [23] as well as for controlling enzyme activities in cells. 24 Here, we make use of this potential and develop a fluorescencebased assay to monitor protein turnover in mammalian cells. We site-specifically incorporate BCNK 16, 18 into low abundant mammalian proteins using an efficient PylRS variant, which allows for fast and selective protein labeling with tetrazinefluorophore conjugates. This extends the arsenal of methods that have been developed in recent years to monitor protein turnover in cells [25] [26] [27] by a fluorescence-based approach that relies on rapid bioorthogonal reactions. As model substrates, we use members
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For internal use, please do not delete. Submitted_Manuscript of the human interleukin 12 (IL-12) family. 28, 29 Interleukins are key signaling molecules in our immune system and as such understanding their biogenesis and degradation is of great interest. Like other secreted proteins, interleukins are produced in the ER and each IL-12 family member is a heterodimeric protein made up of an a and a b subunit. 28, 29 It has recently been shown that IL-12a as well as IL-23a fail to fold in the absence of their bsubunit and are thus rapidly degraded, [30] [31] [32] providing native clients of ER quality control. Our data show that incorporation of BCNK and site-specific fluorophore labeling of IL-12a and IL-23a preserves their normal biogenesis processes and provides an ideal tool to monitor protein turnover in mammalian cells.
Results and Discussion
Non-natural amino acids can be incorporated into interleukin subunits while maintaining their wild-type behavior A major advantage of genetic code expansion is the possibility to label any position within a polypeptide sequence with only minimal modifications to the protein under scrutiny. Here we use a selective and highly efficient PylRS variant (Y271G, C313V, M. barkeri numbering, dubbed BCNKRS, Figure S1A ) 33 for expression of low-abundant interleukins bearing BCNK at defined positions. Beginning with the a subunit of IL-12 (IL-12a, Figure 1A ), we searched for a suitable position to introduce BCNK ( Figure  1B ). Criteria were complete solvent-exposure in the native heterodimeric IL-12 structure as well as no predicted interference with IL-12b heterodimerization. 34 Asp31 (D31) and Gln57 (Q57) fulfilled these criteria ( Figure 1A ). Using BCNKRS and BCNK we could obtain significant expression for the IL-12a constructs, where D31 or Q57 were replaced by an amber stop codon (D31* or Q57*, respectively). Expression did not vary significantly between 0.1 and 1 mM BCNK ( Figure S1B ). At 0.25 mM BCNK, expression levels of IL-12a D31BCNK were still 34±4% (mean±SEM) and for IL-12a Q57BCNK 54±6% (mean±SEM) of the ones observed for the wild-type (wt) protein ( Figure 1C ).
Based on these findings, we next assessed wt-like behavior of the BCNK-bearing IL-12a variants in terms of ER quality control. IL-12a is retained in cells in isolation and forms incorrect disulfide bonds. Only the co-expression of IL-12b induces correct folding. 30 IL-12a D31BCNK showed wt behavior and was retained in cells in isolation and only secreted efficiently upon co-expression of IL-12b, including modification of its glycan residues in the Golgi, 30 arguing that ERQC works properly on the modified protein ( Figure  1D ). The same behavior was observed for IL-12a Q57BCNK, corroborating the minimally invasive character of BCNK incorporation ( Figure 1E ). Using interleukin-responsive reporter cell lines we could furthermore show that IL-12 containing BCNK was biologically active, also when fluorophore was added, arguing for proper folding in the presence of BCNK and fluorophore ( Figure S1C ). Lastly, extending our approach to IL-23, another IL-12 family member prominently involved in autoimmune reactions and tumor development, 29, 35, 36 we found that BCNK could also be incorporated site-specifically into this protein while preserving normal ERQC 31 and biological activity (Figure S1D-G). 
Rapid bioorthogonal fluorescence labeling of interleukin subunits
Having established efficient incorporation of BCNK into IL-12a and IL-23a while preserving wt-like behavior, we proceeded to fluorescent labeling of BCNK-modified proteins. We focused on IL-12a for a detailed characterization. First, our goal was to 10.1002/cbic.201900651 
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Bioorthogonal fluorescence labeling allows to monitor protein turnover
Taken together, these characteristics (wt-like behavior combined with rapid and efficient labeling) provided us with an excellent tool to monitor protein turnover. Toward this end, we first labeled IL-12a containing BCNK at position 31 or 57 with SiR-tetrazine for 15 min. Subsequently, we washed out SiR-tetrazine and added an excess of free BCNK to quench all tetrazine-fluorophore and at the same time maintain translation of the target protein IL-12a. Hence, this approach should allow for observation of selective degradation of the fluorescently labeled protein pool without disturbing global translation in the cell (Schematic in Figure 3 , A and B). Since an UAA was used instead of radioactive amino acids to follow protein degradation in classical pulse-chase experiments, we termed this approach uChase. As expected, we observed a decrease in IL-12a fluorescence for D31BCNK and Q57BCNK in uChase experiments (Figure 3 , C and D, top). Of note, this analysis was based on whole cell lysates, and thus does not depend on any downstream enrichment steps and also works for interleukins as proteins expressed at low levels ( Figure S3A -D). Furthermore, the assay was compatible with either using SiRtetrazine ( Figure 3C ) or Bodipy-tetramethylrodamine (B-TMR)tetrazine ( Figure 3D ) as fluorophore-tetrazine conjugates to label IL-12a. Starting from steady-state, immunoblots revealed that the overall level of IL-12a essentially remained constant over the time of the chase, as initially hypothesized (Figure 3 , C and D, middle). The slight increase in protein levels can likely be attributed to the necessary washing steps before labeling, which were performed in the absence of BCNK. This will deplete cells of BCNK during these steps and thus lead to degradation of a small amount of IL-12a before the BCNK excess is added and translation from Amber codon-containing transcripts can resume. In agreement with previous studies, 30 , 32 the half-life for IL-12a degradation obtained by our new uChase assay was 2.5±0.3 hrs (using D31* and SiR) and 2.2±0.2 hrs (using Q57* and B-TMR) (Figure 3 , C and D, 10 .1002/cbic.201900651
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For internal use, please do not delete. Submitted_Manuscript bottom), showing that labeling position and choice of fluorophore did not significantly affect the outcome of our experiment. Furthermore, neither BCNK incorporation nor SiR-labeling ( Figure  S4, A and B ) significantly changed the half-life of IL-12a in cycloheximide (CHX) chases, underscoring the minimally invasive character of our approach and establishing uChase as a new way to monitor protein degradation. Two assays were performed to confim that our assay monitored ERAD. 10 .1002/cbic.201900651
Accepted Manuscript
FULL PAPER
For internal use, please do not delete. Submitted_Manuscript Degradation of IL-12a in our uChase assay was mediated by the proteasome as expected for an ERAD substrate, since it could be inhibited by MG132 ( Figure 3E, bottom) . As a further test we used a dominant negative mutant of the ERAD E3 ubiquitin ligase Hrd1 (Hrd1 C291S ) 37 . This mutant decelerated degradation of IL-12a in CHX chases ( Figure S4C ) and to a similar extent degradadtion of B-TMR-labelled IL-12a Q57BCNK in uChase assays ( Figure S4 , D and E) further validating our assay as a tool to monitor ERAD.
To show a more general applicability of our approach we additionally analyzed IL-23a L150BCNK. For this protein, degradation occurred with a half-life of less than 2h, and was again not significantly affected by incorporation of BCNK ( Figure  S4F ). When BCNK was labeled with B-TMR, our uChase approach again yielded a similar half-life like CHX chases 31 ( Figure S4, F and G) showing that our approach can also be extended to other proteins with a more rapid cellular turnover.
Development of a fluorescence-based pulse-chase assay
So far, our approach was similar to classical CHX-chases as we started from a steady state pool of proteins, and then monitored its degradation. Ideally, as possible by radioactive labeling 10 and recently developed techniques for cytoplasmic proteins, 13 one would like to label the protein of interest produced within a defined time interval, and then monitor its cellular fate. This e.g. allows to analyze transport processes and post-translational modifications like changes in glycosylation with temporal resolution. 38 To assess, if such an approach ( Figure 4A ) was in reach with our setup, we first analyzed how long BCNK needed to be added to cells in order to observe expression of IL-12a Q57BCNK. Even after as little as 30 min we observed sufficient expression of IL-12a Q57BCNK for detection by immunoblotting ( Figure 4 In these experiments, a half-life of 1.1±0.1 hrs (from input samples) was observed for IL-12a Q57BCNK. This may argue, that on a molecular level an IL-12a pool produced within only a 1hr pulse period differs to some extent from the steady-state pool. It should be noted that IL-12a forms different redox species in cells, including homodimers 30 , whose formation has not been kinetically analyzed yet but may impact degradation and give rise to this behavior. This further highlights the importance of pulsechase types of approaches. Since we were starting from a small pool of IL-12a Q57BCNK (Figure 4 , B and C), the decrease in the pool of fluorescently labeled protein (Figure 4 , D and E) was accompanied by an increase in overall IL-12a Q57BCNK levels during the 4 hr chase, where BCNK was present that allows for the synthesis of new, non-fluorescent IL-12a Q57BCNK molecules ( Figure 4F ). Taken together, these data show that a pulse-chase approach is also possible using a uChase, which opens up further future fluorescence-based applications. 10 .1002/cbic.201900651
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Conclusions
In this study, we have established a minimally-invasive approach to monitor protein turnover in cells. Toward this end we incorporated the tetrazine-reactive amino acid BCNK into different positions of two human interleukins, IL-12 and IL-23. BCNK incorporation was completely compatible with wt-like folding, assembly, cellular quality control and function of the interleukins. These characteristics allowed us to establish uChase as a new assay to monitor protein degradation in mammalian cells. Our approach does not depend on any tag or other significant modifications of the protein of interest. It is furthermore compatible with different proteins even at very low expression levels, allows to monitor rapid degradation processes, and does not depend on any downstream enrichment processes (e.g. immunoprecipitation, where a specific antibody is needed). Furthermore, no global inhibition of translation is needed as in CHX chases, which may have pleiotropic effects and e.g. lead to the unwanted degradation of ERAD factors relevant for the protein under scrutiny. It should be noted that due to the low expression levels of interleukins, background labeling is present, which was mostly absent for proteins expressed at higher levels ( Figure S3 ). While, we monitor protein turnover via in-gel fluorescence, we envision that our approach may be amenable to future microscopy-/FACS-based live cell assays to monitor protein degradation directly in living cells when expression is sufficiently high. This would be a major advantage over currently available approaches. Using overexpressed proteins, however, of course always comes with the caveat of possibly altered turnover if important factors become limiting. We show that the technique we have established also provides the basis for more complex fluorescence-based pulsechase assays. Furthermore, since we could confirm receptor binding of our modified interleukins, fluorescently modified interleukins may provide a valuable tool to assess the characteristics of their receptor engagement and/or include other chemically reactive probe to selectively modulate their functions and thus goes beyond a tool to measure protein turnover.
Experimental Section
See supporting information -details on materials and experimental procedures used, synthesis of small molecules and additional figures.
